ArticleJournal of experimental & clinical cancer research : CR2019

DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.

Ssu-Chuan Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.